Zhihong (Joe) Zhang

Company: Burning Rock Biotech

Job title: Chief Technology Officer

Seminars:

Utilities of ctDNA for Identifying and Tracking Molecular Residual Disease in Solid Tumors 12:40 pm

Circulating tumor DNA is an important biomarker in MRD determination, the detection technology is more sophisticated than therapy selection ctDNA assay.  Considering the prognosis value of using ctDNA to determine MRD status in solid tumor, a number of MRD solutions had been invented and implemented in many clinical studies.  Burning Rock a tumor-informed personalized MRD…Read more

day: Day 1 Track B AM